GCR Nominates Axinn for Firm of the Year and Litigator of the Year
February 17, 2021
Global Competition Review has nominated Axinn for two GCR Awards for excellence in 2020.
Axinn earned a nomination for "Firm of the Year - Americas" due to its work on some of today’s most noteworthy matters, including representing Google in investigations by the U.S. Department of Justice and State of Texas; Thermo Fisher in its proposed $12.5 billion acquisition of QIAGEN NV; Tufts Health Plan in its merger with Harvard Pilgrim Health Care; Tyson Foods in multiple treble damages class action claims; and Alvogen in the Generic Pharmaceuticals Antitrust Pricing Litigation.
Axinn partner Rachel Adcox earned a second nomination for" Litigator of the Year" for her work as lead counsel on several major class action claims and multi-district antitrust litigation cases, including her representation of Tyson Foods in multiple major treble-damage class action litigations and regulatory investigations alleging industry-wide conspiracies to raise the prices of broiler chickens, pork, turkey, and beef, as well as a conspiracy to depress broiler grower pay. She is also lead counsel defending Alvogen Inc. in the sprawling Generic Drugs MDL, a suit alleging participation in an industry-wide conspiracy to raise prices of generic medications through the allocation of markets.
The finalists were chosen by Global Competition Review’s editorial team and GCR readers will decide the winners through an online vote. The winners will be announced in a series of special reports that GCR will begin publishing in April.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
Client Alerts
Antitrust
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Awards & Recognitions
Antitrust
Merger Remedies Back in Vogue Under Trump
Media Mentions
Antitrust
Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation
Axinn Viewpoints
Intellectual Property
A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness
Axinn Viewpoints
Intellectual Property